tiprankstipranks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market
Holding GANX?
Track your performance easily

Gain Therapeutics (GANX) Stock Investors

249 Followers
Based on 778,277 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GANX
On average, investors allocate 0.00% of their portfolios to GANX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 778,277 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GANX

0.4%
Last 7
Days
10.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GANX, out of 778,277 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GANX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.36%
$1.04
Increased
0.50%
$1.13
Reduced
0.48%
$1.74
Based on the activity of 14,834 investors who made their portfolios public
The table shows changes in GANX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GANX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Plug Power
5.22%
+0.64%
-0.50%
2.40B
Industrials
DraftKings
4.96%
+0.43%
+0.42%
32.98B
Consumer Cyclical
Lucid Group
5.71%
-0.30%
+2.44%
9.91B
Consumer Cyclical
Viking Therapeutics
4.16%
-0.13%
-0.10%
4.78B
Healthcare
Nio
9.35%
-0.13%
-1.10%
9.37B
Consumer Cyclical
Riot Platforms
5.16%
+0.26%
+4.29%
4.24B
Financial
Marathon Digital Holdings
5.48%
+0.75%
+3.49%
6.67B
Financial
General Motors
4.97%
+0.03%
-0.72%
56.93B
Consumer Cyclical
Recursion Pharmaceuticals
3.50%
+0.28%
+3.66%
3.05B
Healthcare
Trade Desk
4.54%
+0.43%
+1.59%
60.14B
Technology
Based on the activity of 778,277 active portfolios
Open your Smart Portfolio

GANX Investor Analysis

GANX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
2.4%
of GANX holders
are under 35
Average Segment Performance
Average P/E Ratio31.21
Beta10.88
Dividend Yield3.85%
GANX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
53.7%
of GANX holders
are between 35–55
Average Segment Performance
Average P/E Ratio28.03
Beta19.53
Dividend Yield3.58%
GANX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
43.9%
of GANX holders
are over 55
Average Segment Performance
Average P/E Ratio26.38
Beta10.27
Dividend Yield3.51%
Overview of age group and performance of GANX stock investors
See who invests in GANX according to age group and performance.

FAQ

How many retail Investors hold GANX?
<0.1% of TipRanks' retail investors hold GANX in their portfolios.
    What is GANX Investor Sentiment?
    GANX’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of GANX in the last 7 days?
      ▼ 0.4% of TipRanks' retail investors changed their holding of GANX in the last 7 days.
        What percentage of retail investors changed their holding of GANX in the last 30 days?
        ▲ 10.6% of TipRanks' retail investors changed their holding of GANX in the last 30 days.
          What is the average age of retail investors who hold GANX?
          The average age of GANX Holders is between 35–55.
            What other stocks have GANX investors also bought?
            GANX Investors also bought PLUG, DKNG, LCID, VKTX, NIO, RIOT, MARA, GM, RXRX, TTD.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              CORCencora
              ANGOAngioDynamics
              BCRXBioCryst
              BIIBBiogen
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis